Skip to main content
News
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Contact
FAQ
Request Info
Email Alerts
Site Search
Search query
News
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Contact
FAQ
Request Info
Email Alerts
Search query
News Releases
News
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Contact
FAQ
Request Info
Email Alerts
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
Sep 20, 2023
AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
Download PDF
PDF format download (opens in new window)
Sep 13, 2023
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology
Download PDF
PDF format download (opens in new window)
Aug 03, 2023
AbCellera Reports Q2 2023 Business Results
Download PDF
PDF format download (opens in new window)
Jul 24, 2023
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
Download PDF
PDF format download (opens in new window)
Jul 06, 2023
AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023
Download PDF
PDF format download (opens in new window)
May 29, 2023
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
Download PDF
PDF format download (opens in new window)
May 24, 2023
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
Download PDF
PDF format download (opens in new window)
May 04, 2023
AbCellera Reports Q1 2023 Business Results
Download PDF
PDF format download (opens in new window)
Apr 17, 2023
AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023
Download PDF
PDF format download (opens in new window)
Apr 11, 2023
AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023
Download PDF
PDF format download (opens in new window)
Apr 06, 2023
AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
Download PDF
PDF format download (opens in new window)
Mar 22, 2023
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
Download PDF
PDF format download (opens in new window)
Mar 14, 2023
AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
Download PDF
PDF format download (opens in new window)
Feb 23, 2023
AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
Download PDF
PDF format download (opens in new window)
Feb 21, 2023
AbCellera Reports Full Year 2022 Business Results
Download PDF
PDF format download (opens in new window)
Feb 01, 2023
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
Download PDF
PDF format download (opens in new window)
Jan 24, 2023
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
Download PDF
PDF format download (opens in new window)
Jan 19, 2023
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
Download PDF
PDF format download (opens in new window)
Jan 04, 2023
AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
Download PDF
PDF format download (opens in new window)